
    
      Patients were diagnosed with sarcoidosis according to the criteria of the latest American
      Thoracic Society (ATS)/European Respiratory Society (ERS)/World Association of Sarcoidosis
      and Other Granulomatous (WASOG) Disorders statement on sarcoidosis. Primary outcome
      measurement was respiratory muscle strength, secondary outcomes were, exercise capacity
      quality of life, fatigue and depression.
    
  